Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent...
7 insider purchases on record · latest filing 2018-05-31.
Insiders have also filed 177 sale transactions at KNSA.